Investigation of the relationships between perceived causes of COVID-19, attitudes towards vaccine and level of trust in information sources from the perspective of Infodemic: the case of Turkey

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 26 Jun 2021)

 

Investigation of the relationships between perceived causes of COVID-19, attitudes towards vaccine and level of trust in information sources from the perspective of Infodemic: the case of Turkey
The main purpose in this study carried out from the perspective of infodemic was to investigate the relationships between individuals’ perceived causes of COVID-19, their attitudes towards vaccine and their le…
Authors: Şemsi Nur Karabela, Filiz Coşkun and Haydar Hoşgör
Citation: BMC Public Health 2021 21:1195
Content type: Research
Published on: 23 June 2021

The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World

Clinical Therapeutics
Volume 43 Issue 4 p651-792
http://www.clinicaltherapeutics.com/current

 

COVID
The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World
Ravi Jhaveri
Published online: March 23, 2021
Abstract
The approval of the coronavirus disease 2019 (COVID-19) mRNA vaccines brought much optimism to efforts to end the pandemic. A recombinant adenovirus vaccine recently received emergency use authorization, and several other vaccines are likely to follow. These vaccines all use relatively new vaccine production platforms to produce the severe acute respiratory syndrome coronavirus 2 Spike protein. This review discusses how these platforms work, what advantages they offer, and the gaps that remain in public health efforts to control the COVID-19 pandemic.

Managing borders during public health emergencies of international concern: a proposed typology of cross-border health measures

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 26 Jun 2021]

 

Managing borders during public health emergencies of international concern: a proposed typology of cross-border health measures
Authors: Kelley Lee, Karen A. Grépin, Catherine Worsnop, Summer Marion, Julianne Piper and Mingqi Song
Content type: Research
21 June 2021

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

US Case Reports of Cerebral Venous Sinus Thrombosis

JAMA
June 22/29, 2021, Vol 325, No. 24, Pages 2419-2512
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Isaac See, MD; John R. Su, MD, PhD, MPH; Allison Lale, MD, MPH; et al.
free access
JAMA. 2021;325(24):2448-2456. doi:10.1001/jama.2021.7517
This study describes the reported US cases of cerebral venous sinus thrombosis (CVST) with thrombocytopenia following vaccination with Ad26.COV2.S, the COVID-19 vaccine produced by Janssen/Johnson & Johnson.

Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers

JAMA
June 22/29, 2021, Vol 325, No. 24, Pages 2419-2512
https://jamanetwork.com/journals/jama/currentissue

 

Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Yoel Angel, MD, MBA; Avishay Spitzer, MD; Oryan Henig, MD; et al.
free access has active quiz
JAMA. 2021;325(24):2457-2465. doi:10.1001/jama.2021.7152
This cohort study estimates the association between Pfizer-BioNTech BNT162b2 vaccination and symptomatic and asymptomatic SARS-CoV-2 infections among health care workers more than 7 days after receipt of a second vaccine dose.

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

JAMA
June 22/29, 2021, Vol 325, No. 24, Pages 2419-2512
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
Li Tang, PhD; Diego R. Hijano, MD, MSc; Aditya H. Gaur, MD, MBBS; et al.
free access has active quiz
JAMA. 2021;325(24):2500-2502. doi:10.1001/jama.2021.6564
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest

JAMA
June 22/29, 2021, Vol 325, No. 24, Pages 2419-2512
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest
Stacy Wood, PhD; Kevin Schulman, MD
free access
JAMA. 2021;325(24):2435-2436. doi:10.1001/jama.2021.7707
This Viewpoint explains how vaccine apathy rather than hesitancy may lead to population undervaccination, and uses marketing principles to explain how public health messaging might differ to persuade apathetic persons to be immunized to achieve more widespread COVID-19 protection.

Overview of the Issue

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Changes in Strength of Recommendation and Perceived Barriers to Human Papillomavirus Vaccination: Longitudinal Analysis of Primary Care Physicians, 2008-2018

Journal of Pediatrics
Volume 234 p1-296
http://www.jpeds.com/current

 

Original Articles
Changes in Strength of Recommendation and Perceived Barriers to Human Papillomavirus Vaccination: Longitudinal Analysis of Primary Care Physicians, 2008-2018
Jessica R. Cataldi, et al
Published online: March 06, 2021
p149-157.e3

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban

The Lancet
Jun 26, 2021 Volume 397 Number 10293 p2439-2536, e17-e19
https://www.thelancet.com/journals/lancet/issue/current

 

Clinical Picture
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
Katharina Guetl, Thomas Gary, Reinhard B Raggam, Johannes Schmid, Albert Wölfler, Marianne Brodmann

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

Nature
Volume 594 Issue 7864, 24 June 2021
https://www.nature.com/nature/volumes/594/issues/7864

 

Article | 10 May 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Immunization of macaques with nanoparticle-conjugated receptor-binding domain of SARS-CoV-2 adjuvanted with 3M-052 and alum results in cross-neutralizing antibodies against bat coronaviruses, SARS-CoV and SARS-CoV-2 variants, and may provide a platform for developing pan-coronavirus vaccines.
Kevin O. Saunders, Esther Lee, Barton F. Haynes

Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 26 Jun 2021)

 

Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19
Wenhui Mao, Osondu Ogbuoji, David Watkins, Ipchita Bharali, Eric Boateng, Mohamed Mustafa Diab, Duah Dwomoh, Dean T. Jamison, Preeti Kumar, Kaci Kennedy McDade, Justice Nonvignon, Yewande Ogundeji, Fan-Gang Zeng, Armand Zimmerman, Gavin Yamey
Collection Review | published 24 Jun 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003675

COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 26 Jun 2021)

 

COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control
Seth C. Inzaule, Pascale Ondoa, Marguerite Massinga Loembe, Yenew Kebede Tebeje, Ahmed E Ogwell Ouma, John N. Nkengasong
Collection Review | published 23 Jun 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003666

The 2021 Ebola virus outbreak in Guinea: Mistrust and the shortcomings of outbreak surveillance

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 26 Jun 2021)

 

Viewpoints
The 2021 Ebola virus outbreak in Guinea: Mistrust and the shortcomings of outbreak surveillance
Manuel Raab, Emmanuelle Roth, Vinh-Kim Nguyen, Guenter Froeschl
| published 24 Jun 2021 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0009487
Introduction
In February 2021, an outbreak of Ebola virus disease (EVD) was declared in the N’Zérékoré prefecture, located in the southeastern area of Guinea known as “Forest Guinea” [1]. This region is where the 2013 to 2016 West African epidemic—the largest Ebola epidemic to date—started. In the aftermath, Forest Guinea gained the status of a high-risk region for EVD and other viral haemorrhagic fevers [2]. Consequently, outbreak surveillance and preparedness planning have focused on preparing for a recurrence, such as the 2021 resurgence of Ebola.
Surveillance efforts aim for rapid containment through early detection, specific treatments, and an efficient vaccine. In fact, efforts deployed in the region appear to have detected the current resurgence within a time frame of somewhat less than 1 month. Local communities view the current response through the lens of the earlier outbreak and the preparedness efforts that followed. The response to the 2013 to 2016 epidemic in Forest Guinea was characterised by deep mistrust and violence. In its aftermath, preparedness efforts have been met with scepticism in the population, including healthcare workers, with regard to the ability of the public health system being able to manage future outbreaks effectively…

Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study

PLoS One
http://www.plosone.org/
[Accessed 26 Jun 2021]

 

Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study
Chareeya Thanee, Wanitchaya Kittikraisak, Chalinthorn Sinthuwattanawibool, Koonkoaw Roekworachai, Arunee Klinklom, Katesiree Kornsitthikul, Suwadee Jirasakpisarn, Ussanee Srirompotong, Malinee Chittaganpitch, Fatimah S. Dawood, Piyarat Suntarattiwong, Joshua A. Mott, Tawee Chotpitayasunondh
Research Article | published 25 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0253561

Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis

PLoS One
http://www.plosone.org/
[Accessed 26 Jun 2021]

 

Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis
Tapati Dutta, Jon Agley, Beth E. Meyerson, Priscilla A. Barnes, Catherine Sherwood-Laughlin, Jill Nicholson-Crotty
Research Article | published 25 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0253318

Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti

PLoS One
http://www.plosone.org/
[Accessed 26 Jun 2021]

 

Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti
Cynthia Riviere, Tatiana Bell, Yonie Cadot, Christian Perodin, Benedict Charles, Claudin Bertil, Jazreel Cheung, Shalmali Bane, Hoi Ching Cheung, Jean William Pape, Marie Marcelle Deschamps
Research Article | published 24 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0252310

The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” – A Systematic Review

Risk Management and Healthcare Policy
https://www.dovepress.com/risk-management-and-healthcare-policy-archive56
[Accessed 26 Jun 2021]

 

Review
The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” – A Systematic Review
Wake AD
Risk Management and Healthcare Policy 2021, 14:2609-2623
Published Date: 21 June 2021

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

Science
25 June 2021 Vol 372, Issue 6549
http://www.sciencemag.org/current.dtl

 

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
By Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, David K. Butler, Ashley D. Otter, Katia Menacho, Marianna Fontana, Angelique Smit, Jane E. Sackville-West, Teresa Cutino-Moguel, Mala K. Maini, Benjamin Chain, Mahdad Noursadeghi, UK COVIDsortium Immune Correlates Network, Tim Brooks, Amanda Semper, Charlotte Manisty, Thomas A. Treibel, James C. Moon, UK COVIDsortium Investigators, Ana M. Valdes, Áine McKnight, Daniel M. Altmann, Rosemary Boyton

 

Science25 Jun 2021 : 1418-1423 Open Access
Previous infection results in enhanced variant cross-protective T and B cell responses to a single BNT162b2 vaccine dose.

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Science
25 June 2021 Vol 372, Issue 6549
http://www.sciencemag.org/current.dtl

 

Reports
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
By Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, Leah J. Homad, Vanessa Rubin, Hayley Glantz, Moni Neradilek, Emilie Seydoux, Madeleine F. Jennewein, Anna J. MacCamy, Junli Feng, Gregory Mize, Stephen C. De Rosa, Andrés Finzi, Maria P. Lemos, Kristen W. Cohen, Zoe Moodie, M. Juliana McElrath, Andrew T. McGuire
Science25 Jun 2021 : 1413-1418 Open Access
Previous infection results in enhanced vaccine-induced immune protection against variant B.1.351 and other variants.

For WHO leader, a ‘feeling that we’re failing’

Science
25 June 2021 Vol 372, Issue 6549
http://www.sciencemag.org/current.dtl

 

In Depth
For WHO leader, a ‘feeling that we’re failing’
By Jon Cohen
Science25 Jun 2021 : 1376-1377 Full Access
Tedros Adhanom Ghebreyesus had expected more social responsibility in the face of a global crisis.
Few have spoken out as forcefully against the global disparity in COVID-19 vaccine distribution as Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO). Tedros, as he prefers to be called, has labeled the inequity “vaccine apartheid” and a “catastrophic moral failure” that has led to a “two-track pandemic.” A global procurement scheme by WHO and other parties to supply vaccines to poorer countries, the COVID-19 Vaccines Global Access (COVAX) Facility, has not had much impact so far.

Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico

Vaccine
Volume 39, Issue 25 Pages 3311-3454 (8 June 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/25

 

Research article Open access
Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico
Jose Luis Arredondo, Sandra Maria Villagomez Martinez, Maria Concepcion Morales, Stephanie Meyer, … Cesar Mascareñas
Pages 3388-3396

Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey

Vaccine
Volume 39, Issue 25 Pages 3311-3454 (8 June 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/25

 

Research article Full text access
Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey
Mariangela F. Silveira, Cristian T. Tonial, Ana Goretti K. Maranhão, Antonia M.S. Teixeira, … Cesar G. Victora
Pages 3404-3409

Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data

Vaccine
Volume 39, Issue 25 Pages 3311-3454 (8 June 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/25

 

Research article Open access
Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data
Gloria Ikilezi, Steven D Bachmeier, Ian E Cogswell, Emilie R Maddison, … Angela E Micah
Pages 3410-3418

Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey

Vaccine
Volume 39, Issue 25 Pages 3311-3454 (8 June 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/25

 

Research article Open access
Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey
Alison M. Kraigsley, Kristine A. Moore, Amanda Bolster, Maya Peters, … Joseph S. Bresee
Pages 3419-3427

Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

(Accessed 26 Jun 2021)
Open Access Article
Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales
by Mariam Al-Sanafi and Malik Sallam
Vaccines 2021, 9(7), 701; https://doi.org/10.3390/vaccines9070701 – 25 Jun 2021
Abstract
Acceptance of coronavirus disease 2019 (COVID-19) vaccination appears as a decisive factor necessary to control the ongoing pandemic. Healthcare workers (HCWs) are among the highest risk groups for infection. The current study aimed to evaluate COVID-19 vaccine acceptance among HCWs in Kuwait, with […]

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out
by Ghina R. Mumtaz, Fadi El-Jardali, Mathilda Jabbour, a Harb, aith J. Abu-Raddad and Monia Makhoul
Vaccines 2021, 9(7), 697; https://doi.org/10.3390/vaccines9070697 – 25 Jun 2021
Abstract
Four months into the SARS-CoV-2 vaccination campaign, only 10.7% of the Lebanese population have received at least one dose, raising serious concerns over the speed of vaccine roll-out and its impact in the event of a future surge. Using mathematical modeling, we assessed […

Predictors of Intention to Vaccinate against COVID-19 in the General Public in Hong Kong: Findings from a Population-Based, Cross-Sectional Survey

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Predictors of Intention to Vaccinate against COVID-19 in the General Public in Hong Kong: Findings from a Population-Based, Cross-Sectional Survey
by Elsie Yan, aniel W. L. Lai and Vincent W. P. Lee
Vaccines 2021, 9(7), 696; https://doi.org/10.3390/vaccines9070696 – 25 Jun 2021
Abstract
Vaccination is one of the most effective ways to stop the spread of COVID-19. Understanding factors associated with intention to receive COVID-19 vaccines is the key to a successful vaccination programme. This cross-sectional study explored the rate of vaccination intention and identified its […]

Characteristics of Healthcare Workers Vaccinated against Influenza in the Era of COVID-19

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Characteristics of Healthcare Workers Vaccinated against Influenza in the Era of COVID-19
by Giorgia Della Polla, rancesca Licata, Silvia Angelillo, Concetta Paola Pelullo, Aida Bianco and
Italo Francesco Angelillo
Vaccines 2021, 9(7), 695; https://doi.org/10.3390/vaccines9070695 – 24 Jun 2021
Abstract
Understanding the potential impact of COVID-19 on receiving influenza vaccination among healthcare workers (HCWs) is of utmost importance. The purposes of the present cross-sectional study were to describe the characteristics and to explore the predictors of receiving influenza vaccination among a large cohort […]

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 26 Jun 2021
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 26 Jun 2021
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 26 Jun 2021
[No new, unique, relevant content]

 

Financial Times
https://www.ft.com/
News in-depth
Indian economy
India’s stricken countryside threatens to undermine recovery
June 27, 2021

Coronavirus latest: Brazil’s Covid inquiry hears testimony over controversial vaccine deal
Brazil’s Covid inquiry hears testimony over controversial vaccine deal
June 25, 2021

Coronavirus latest: Almost half of employed adults in Britain commuting, ONS finds
Israel to reimpose mask requirement despite vaccine success
June 25, 2021

 

Forbes
http://www.forbes.com/
Accessed 26 Jun 2021
8 hours ago
CDC: 4,115 Fully Vaccinated Have Been Hospitalized Or Died With Breakthrough Covid-19 Infections
Although the Covid-19 vaccines offer very good protection, they are not perfect. Covid-19 infections, hospitalizations, and deaths can still occur.
By Bruce Y. Lee Senior Contributor

Breaking  |  
Jun 25, 2021
WHO Urges Fully Vaccinated People To Continue Wearing Masks As Delta Variant Spreads—But No Word From CDC
“People cannot feel safe just because they had the two doses” in areas where community transmission is high, one official said.
By Alison Durkee Forbes Staff

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 26 Jun 2021
[No new, unique, relevant content]

 

Foreign Policy
http://foreignpolicy.com/
Accessed 26 Jun 2021
Review
The First Draft Account of the U.K.’s COVID-19 Catastrophe Is Damning
A new book gives the backstory of a dysfunctional early response.
By Jamie Maxwell, a political journalist in Glasgow, Scotland.

Argument
Demands for a Lab Leak Investigation Are a Dangerous Distraction
U.S.-China cooperation is vital for global health efforts.
By Deborah Seligsohn, an assistant professor of political science at Villanova University.
June 18, 2021

 

New Yorker
http://www.newyorker.com/
Accessed 26 Jun 2021
Medical Dispatch
The Delta Variant Is a Grave Danger to the Unvaccinated
One half of America is protected. The other is approaching a perilous moment in the pandemic.
By Dhruv Khullar
June 23, 2021

 

New York Times
http://www.nytimes.com/
Accessed 26 Jun 2021
Health
As Parents Forbid Covid Shots, Defiant Teenagers Seek Ways to Get Them
Most medical consent laws require parental permission for minors to get a vaccine. Now some places are easing restrictions for Covid shots while others are proposing new ones.
By Jan Hoffman
PRINT EDITION Teens’ New Way To Defy Parents: Getting Vaccine| June 27, 2021, Page A1

Asia Pacific
In India, concern mounts over a variant called Delta Plus.
The version of the virus has been found in several other countries, too. Officials say that they are gathering data about its strength and emphasize that vaccines are likely to still offer protection.
By Sameer Yasir June 25

Asia Pacific
Indonesia’s Doctors Got Vaccinated With Sinovac, and Got Sick
Facing increased cases and a deadly variant, the Indonesian health system is under strain, as doctors become patients.
By Hannah Beech and Muktita Suhartono June 25

Americas
Brazil Passes 500,000 Covid Deaths, a Tragedy With No Sign of Letup
With 2.7 percent of the world’s population, Brazil has suffered 13 percent of the Covid-19 fatalities, and the pandemic there is not abating.
PRINT EDITION June 25, 2021

 

Washington Post
https://www.washingtonpost.com/
Accessed 26 Jun 2021
China says no strings attached to vaccine shipments overseas
BEIJING — China said Saturday that it provides vaccines to other countries with no political conditions attached, responding to a story by The Associated Press saying China pressured Ukraine into withdrawing from a multi-country statement on human rights in China’s Xinjiang region by threatening to withhold a COVID-19 vaccine shipment.
A statement from the Chinese Foreign Ministry said it welcomed Ukraine’s decision to take its name off the statement at a meeting of the U.N. Human Rights Council in Geneva, adding “we haven’t heard that Ukraine has encountered any difficulty in importing vaccines from China.”
The Associated Press, citing diplomats from two Western countries, reported that Ukraine had pulled its name from the statement Thursday after China warned it would block a planned shipment of at least 500,000 doses of COVID-19 vaccines unless it did so. The diplomats spoke on condition of anonymity because they were not authorized to discuss the matter publicly…
Associated Press · Jun 26, 2021

Think Tanks et al

Think Tanks et al
 
 
Brookings
http://www.brookings.edu/
Accessed 26 Jun 2021
[No new digest content identified]
 
 
Center for Global Development [to 26 Jun 2021]
http://www.cgdev.org/page/press-center
Event
Who To Prioritise for C19 Vaccines? A Systematic Literature Search and Narrative Review of C19 Models
6/30/21
How best to prioritise COVID-19 vaccination within and between countries has been a public health and an ethical challenge for decision-makers globally, especially given the vaccine supply is limited in the short and medium term. Epidemiological and economic models can support this decision by providing an assessment of the potential health and broader societal impact of competing prioritisation strategies (e.g., age based strategies, strategies based on the occupation or social networks).
 
 
Chatham House [to 26 Jun 2021]
https://www.chathamhouse.org/
Accessed 26 Jun 2021
Members event – Vaccine diplomacy at a time of extreme rivalries
How have vaccine nationalism and vaccine diplomacy become key components of geopolitics?
30 June 2021 — 12:00PM TO 1:00PM

Explainer Video – Vaccine passports: What they are, and are they useful?
Chatham House experts from the Global Health Programme tackle the main questions and issues around the use of vaccine passports.
23 June 2021

 
 

CSIS
https://www.csis.org/
Accessed 26 Jun 2021
Podcast Episode
Upcoming Event
Assessing the 2021 G7 Summit: The Sherpa Perspective
June 30, 2021

Upcoming Event
Building Resilience: Implementing Primary Care and Immunization Programs in the Covid-19 Context
June 28, 2021

Report
Global Covid-19 Vaccine Distribution Handbook
June 23, 2021 | By Daniel F. Runde, Conor M. Savoy, Janina Staguhn

 
 
Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
[No new digest content identified]

Vaccines and Global Health: The Week in Review :: 20 June 2021

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version A pdf of the current issue is available here: 

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

G7 – COVID Doses/COVAX

Milestones :: Perspectives :: Research

 

G7 – COVID Doses/COVAX

UNICEF welcomes G7 leaders’ commitments to donate COVID vaccine doses, calls for accelerated timetable
Statement by UNICEF Executive Director Henrietta Fore
NEW YORK, 13 JUNE 2021 – “We welcome the commitment this week by leaders of G7 nations to accelerate the rollout of safe, effective, accessible and affordable vaccines for the poorest countries, with a goal toward ending the pandemic in 2022. Equitable access to COVID-19 vaccines represents the clearest pathway out of this pandemic for all of us — children included, and commitments announced by G7 members last week are an important step in this direction.

“UNICEF is particularly pleased that some of the dose donations will be made available immediately to supplement ongoing shortfalls. However, time is still of the critical essence.

“UNICEF thanks G7 member states for their pledges and continued support. UNICEF also thanks all our ambassadors and supporters who are sharing their voices in extending a call for immediate and significant dose donations. If we are to make good on the collective pledge of ending the pandemic next year, much work remains.

 

“Even as many citizens in high-income countries begin to contemplate post-vaccination life, in low-income countries, the future appears quite bleak. More people have died of COVID-19 already this year than in the whole of 2020, led by outbreaks in numerous countries where vaccines remain out of reach. We are particularly worried about the surges in South America, Asia and Africa.

“As the pandemic rages, the virus mutates and produces new variants that could potentially threaten the vaccinated and unvaccinated alike. We are in a fierce race. Donating doses now is smart policy that speaks to our collective best interests.

“Several forecasts suggest that G7 countries will have enough vaccine supplies to donate 1 billion doses by as early as the end of 2021.

“In addition to these generous vaccine pledges, UNICEF and the many organizations and countries involved with distribution and readiness need clear timelines regarding when the vaccines will be available. This is a particularly important element for successfully delivering the vaccines in countries with poor health infrastructure.

“The COVID-19 pandemic has upended the lives of children, affecting every aspect of their lives: their health, education, protection and future prosperity. Now, more than ever, what we do today will have significant and lasting impact on our collective tomorrows. There is no time to waste.”

 

::::::

Outgoing U.N. aid chief slams G7 for failing on vaccine plan
Michelle Nichols
Reuters, 14 June 2021
UNITED NATIONS, June 14 (Reuters) – Outgoing U.N. aid chief Mark Lowcock slammed the Group of Seven wealthy nations on Monday for failing to come up with a plan to vaccinate the world against COVID-19, describing the G7 pledge to provide 1 billion doses over the next year as a “small step.”

 

“These sporadic, small-scale, charitable handouts from rich countries to poor countries is not a serious plan and it will not bring the pandemic to an end,” Lowcock, who steps down on Friday, told Reuters. “The G7, essentially, completely failed to show the necessary urgency.”

The leaders of the United States, Japan, Germany, Britain, France, Italy and Canada met in Cornwall, England over the weekend and also agreed to work with the private sector, the Group of 20 industrialized nations and other countries to increase the vaccine contribution over months to come.
“They took a small step – at that very, very nice resort in Cornwall – but they shouldn’t kid themselves it’s more than a small step and they have still have a lot to do,” Lowcock said.

 

“What the world needed from the G7 was a plan to vaccinate the world. And what we got was a plan to vaccinate about 10% of the population of low and middle income countries, maybe by a year from now or the second half of next year,” he said.

In May, the International Monetary Fund unveiled a $50 billion proposal to end the COVID-19 pandemic by vaccinating at least 40% of the population in all countries by the end of 2021 and at least 60% by the first half of 2022.

“That is the deal of the century,” said Lowcock, adding that the G7 could also have done a lot more to provide vital supplies – such as oxygen ventilators, testing kits and protective equipment – to countries who are going to have to wait longer for vaccines.

[In May 2017, Mr. Mark Lowcock of the United Kingdom was appointed as the UN Under-Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator, and head of the UN Office for the Coordination of Humanitarian Affairs (OCHA)]

 

::::::

G7 Summit was a missed opportunity for action and funding needed to end COVID-19 pandemic
June 16, 2021 by PATH
Last week, leaders from the Group of Seven (G7)—Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States—came together to discuss, among other things, an ambitious goal to build stronger health systems to protect the world from future pandemics.

While we were pleased to see a bold commitment from the US government to donate 500 million doses of the Pfizer-BioNTech COVID-19 vaccine to the world’s lowest income nations, the G7 failed to provide an overall blueprint for investment or action that the world desperately needs to end this pandemic and prepare for the next.

Leaders acknowledged the need to vaccinate a majority of the global population to end the pandemic by 2022 but failed to agree on a global roadmap to bolster political will and spur action to achieve herd immunity. The G7 communique rightly prioritizes increased coordination around global vaccine manufacturing capacity, but again lacked any strategy for how do so. And we were pleased to see ongoing support from G7 nations for the extension of the ACT-Accelerator and increased transparency around vaccine procurement and delivery to both donor and recipient countries, but with the current US$18.1 billion funding gap, meaningful support requires greater funding commitments.

World leaders from the wealthiest countries have a responsibility to act—and fund—an inclusive COVID-19 response that will put an end to the acute phase of the pandemic and save lives. We will continue to demand that G7 leaders back their statements with the funding and outline of tangible action needed to bring the world past the current crisis and prepare for the next.